Concepedia

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

André Goy, Steven H. Bernstein, Brad S. Kahl, Benjamin Djulbegović, Michael J. Robertson, Sven de Vos, Elliot Epner, A. Krishnan, John P. Leonard, Sagar Lonial,

Annals of Oncology · 2008 · 340 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Jesús F. San Miguel, Rudolf Schlag, Nuriet K. Khuageva et al. · New England Journal of Medicine · 2008 · 1.9K citations · Full text

, , +12

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Eva Hoster, Martin Dreyling, Christian Gisselbrecht et al. · Blood · 2007 · 971 citations

, , +11

Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies

Robert Z. Orlowski, Thomas E. Stinchcombe, Beverly S. Mitchell et al. · Journal of Clinical Oncology · 2002 · 763 citations

, , +17

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Richard I. Fisher, Steven H. Bernstein, Brad S. Kahl et al. · Journal of Clinical Oncology · 2006 · 708 citations

, , +15

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Paul G. Richardson, Hannah Briemberg, Sundar Jagannath et al. · Journal of Clinical Oncology · 2006 · 650 citations · Full text

, , +17